Connect your AI

Haemonetics HAE Accounts Receivable

Accounts Receivable at other companies

AbbottABT

$8.21B+12.1%

TFX

TeleflexTFX

$365.53M-21.3%

Boston ScientificBSX

$3.15B+12.4%

MedtronicMDT

$6.64B+2.0%

LivaNovaLIVN

$229.27M+13.5%

ICU MedicalICUI

$201.08M+17.6%

Other financials

Income statement

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

Market cap$3.31B-18.0%

Profitability

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Haemonetics's accounts receivable?: Haemonetics (HAE) reported accounts receivable of $216.86M in Q1 2026.
How has Haemonetics's accounts receivable changed year-over-year?: Haemonetics's accounts receivable increased by 7.0% year-over-year, from $202.66M to $216.86M.
What is the long-term trend for Haemonetics's accounts receivable?: Over 5 years (2021 to 2026), Haemonetics's accounts receivable has grown at a 11.2% compound annual growth rate (CAGR), from $127.56M to $216.86M.
What does accounts receivable mean?: Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.